1. A class action lawsuit is filed against Semler Scientific. 2. The lawsuit alleges false statements regarding a DOJ investigation. 3. Investors can join the case to recover potential losses. 4. The class period for eligibility is from March 2021 to April 2025. 5. Investors are encouraged to participate before the deadline of October 29, 2025.
The lawsuit suggests severe allegations which could harm SMLR's reputation and stock value, reminiscent of previous biotech scandals impacting share prices significantly.
The class action lawsuit indicates significant legal risks that could directly influence investor confidence and SMLR's market performance.
Immediate investor sentiment may shift negatively due to fear and uncertainty surrounding legal proceedings, similar to past incidents causing abrupt price declines.
LOS ANGELES, Sept. 8, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semler Scientific, Inc. ("Semler" or "the Company") (NASDAQ: SMLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between March 10, 2021 and April 15, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before October 29, 2025.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Semler failed to inform investors about a DOJ investigation into alleged violations of the False Claims Act, despite discussing violations in hypothetical terms. Based on this fact, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Semler, investor suffered damages.
Join the case to recover your losses
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/smlr-investors-have-opportunity-to-lead-semler-scientific-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302549583.html
SOURCE The Schall Law Firm